High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis

Author(s):: Messori, A.; Peyvandi, F.; Trippoli, S.; Palla, R.; Rosendaal, F.R.; Mannucci, P.M.

Published: 2018
Publication type: Article / Letter to editor

Date issued: 2018-12-31
Language: English
Is part of: Blood Transfusion == (2018), Vol. 16, no. 2, p. 215-220
hdl: 1887/86619
doi: 10.2450/2017.0352-16
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28686156/